Free 7-day Trial
All Articles and Columns »

Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques Bienaime sells 3,000 Shares

January 08, 2013 | About:
10qk

insider

52 followers
CEO of Biomarin Pharmaceutical, Inc. (BMRN) Jean Jacques Bienaime sells 3,000 shares of BMRN on 01/04/2013 at an average price of $52.24 a share.

Biomarin Pharmaceutical, Inc. has a market cap of $6.51 billion; its shares were traded at around $51.92 with and P/S ratio of 13.2.

This is the annual revenues and earnings per share of BMRN over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of BMRN.


CEO Recent Trades:



  • CEO Jean Jacques Bienaime sold 3,000 shares of BMRN stock on 01/04/2013 at the average price of 52.24. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has decreased by 0.61% since.
  • CEO Jean Jacques Bienaime sold 5,000 shares of BMRN stock on 12/31/2012 at the average price of 48.62. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 6.79% since.
  • CEO Jean Jacques Bienaime sold 17,000 shares of BMRN stock on 12/27/2012 at the average price of 48.37. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 7.34% since.
  • CEO Jean Jacques Bienaime sold 9,000 shares of BMRN stock on 12/21/2012 at the average price of 48.57. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 6.9% since.
  • CEO Jean Jacques Bienaime sold 5,000 shares of BMRN stock on 12/12/2012 at the average price of 50. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 3.84% since.

This is the insider trade history vs. stock price of BMRN. For the complete insider trading history of BMRN, click here.




Directors and Officers Recent Trades:



  • EVP, Technical Operations Robert Baffi sold 20,000 shares of BMRN stock on 01/03/2013 at the average price of 53. Robert Baffi owns at least 100,413 shares after this. The price of the stock has decreased by 2.04% since.
  • Director Richard A Meier sold 10,000 shares of BMRN stock on 01/02/2013 at the average price of 51.25. Richard A Meier owns at least 18,650 shares after this. The price of the stock has increased by 1.31% since.
  • VP, Human Resources Mark Wood sold 10,415 shares of BMRN stock on 12/17/2012 at the average price of 49.17. Mark Wood owns at least 25,646 shares after this. The price of the stock has increased by 5.59% since.
  • Director Richard A Meier sold 5,000 shares of BMRN stock on 12/11/2012 at the average price of 49.71. Richard A Meier owns at least 18,650 shares after this. The price of the stock has increased by 4.45% since.
  • Director Richard A Meier sold 5,000 shares of BMRN stock on 11/29/2012 at the average price of 49.17. Richard A Meier owns at least 18,650 shares after this. The price of the stock has increased by 5.59% since.


For the complete insider trading history of BMRN, click here.
  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership

About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 2.0/5 (1 vote)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide